Publications:125
Video Visit Available
Accepting New Patients
Mount Sinai DoctorsTreats Adults
Accepting New PatientsEmily J Gallagher, MD, PhD
Emily Jane Gallagher (Preferred Name)
Endocrine, Diabetes and Bone Diseases (Endocrinology)
Book an Appointment
About Me
Dr. Emily J. Gallagher is an Associate Professor in the Division of Endocrinology, Diabetes and Bone Disease and Associate Program Director of the Internal Medicine Residency Program. She is also the Director of the Research Track for the Internal Medicine Residency Program.
Dr. Gallagher earned her MB BCh BAO (MD equivalent) with honors from University College Dublin, Ireland and her PhD in Physiology and Medical Physics from the Royal College of Surgeons of Ireland. She is Board Certified in Internal Medicine and Endocrinology and is a Member of the Royal College of Physicians of Ireland (MRCPI). Dr. Gallagher trained in Internal Medicine and Endocrinology at the Mater Miseriordiae University Hospital, Dublin, and completed her postgraduate training in Internal Medicine and Endocrinology at Mount Sinai. She was Chief Fellow in Endocrinology, and was subsequently appointed Assistant Professor of Medicine Endocrinology, Diabetes and Bone Diseases.
She has been Principle Investigator on an Endocrine Fellows Foundation, Fellows Development Research Grant, and a K08 Clinician-Scientist Career Development Award from the NIH / NCI to study the role of hyperlipidemia in breast cancer progression. Dr. Gallagher is co-investigator on a number of NIH-funded studies. She has received a Tisch Cancer Institute at Mount Sinai Junior Scientist Research Award, a Mount Sinai Department of Medicine Junior Faculty Translational Collaborative Research Pilot Award and the Harold and Golden Lamport Research Award.
Dr. Gallagher’s clinical practice is in the field of onco-endocrinology: the management of endocrine and metabolic complications of cancer and its treatments. These complications of oncology treatments include: type 1 and type 2 diabetes drug induced hyperglycemia; dyslipidemia; complications of targeted therapies, small molecule inhibitors and immune checkpoint inhibitors that affect the pancreas, thyroid, pituitary and adrenal glands.
Language
Position
Hospital Affiliations
- Mount Sinai Queens
- The Mount Sinai Hospital
Multi-Disciplinary Training Areas
Cancer Biology [CAB]
About Me
Dr. Emily J. Gallagher is an Associate Professor in the Division of Endocrinology, Diabetes and Bone Disease and Associate Program Director of the Internal Medicine Residency Program. She is also the Director of the Research Track for the Internal Medicine Residency Program.
Dr. Gallagher earned her MB BCh BAO (MD equivalent) with honors from University College Dublin, Ireland and her PhD in Physiology and Medical Physics from the Royal College of Surgeons of Ireland. She is Board Certified in Internal Medicine and Endocrinology and is a Member of the Royal College of Physicians of Ireland (MRCPI). Dr. Gallagher trained in Internal Medicine and Endocrinology at the Mater Miseriordiae University Hospital, Dublin, and completed her postgraduate training in Internal Medicine and Endocrinology at Mount Sinai. She was Chief Fellow in Endocrinology, and was subsequently appointed Assistant Professor of Medicine Endocrinology, Diabetes and Bone Diseases.
She has been Principle Investigator on an Endocrine Fellows Foundation, Fellows Development Research Grant, and a K08 Clinician-Scientist Career Development Award from the NIH / NCI to study the role of hyperlipidemia in breast cancer progression. Dr. Gallagher is co-investigator on a number of NIH-funded studies. She has received a Tisch Cancer Institute at Mount Sinai Junior Scientist Research Award, a Mount Sinai Department of Medicine Junior Faculty Translational Collaborative Research Pilot Award and the Harold and Golden Lamport Research Award.
Dr. Gallagher’s clinical practice is in the field of onco-endocrinology: the management of endocrine and metabolic complications of cancer and its treatments. These complications of oncology treatments include: type 1 and type 2 diabetes drug induced hyperglycemia; dyslipidemia; complications of targeted therapies, small molecule inhibitors and immune checkpoint inhibitors that affect the pancreas, thyroid, pituitary and adrenal glands.
Language
Position
Hospital Affiliations
- Mount Sinai Queens
- The Mount Sinai Hospital
Multi-Disciplinary Training Areas
Cancer Biology [CAB]
Clinical Focus
- Diabetes
- Hyperlipidemia
- Hypopituitarism
- Obesity
- Thyroid Diseases
- Type 1 Diabetes
- Type 2 Diabetes
Video
Education
MD, University College Dublin
Fellowship, Mater Misericordiae University Hospital
MD, University College Dublin
MRCPI, Royal College of Physicians
PhD, Royal College of Surgeons
Residency, Mater Misericordiae University Hospital
Residency, Internal Medicine
Mater Misericordiae University Hospital
Residency, Internal Medicine
Mount Sinai Hospital
Fellowship, Endocrinology, Diabetes and Metabolism
Mater Misericordiae University Hospital
Fellowship, Endocrinology, Diabetes and Metabolism
Mount Sinai Hospital
Certifications
American Board of Internal Medicine
Research
Please visit the Gallagher Laboratory at https://labs.icahn.mssm.edu/gallagherlab/
A complete list of publications can be found at https://www.ncbi.nlm.nih.gov/sites/myncbi/1f1gDxyoohx5v/bibliography/48238446/public/
Locations
Insurance Information
Accepted insurance may vary by the doctor’s office location. Please contact the office directly to obtain the most up-to-date insurance information.
Patients with Cigna Medicare Advantage or Humana Medicare Advantage insurance: Please read this important message before booking to find out if out-of-network costs may apply to your next visit.
- 5 E 98th Street, 3rd Floor, New York, NY, 10029
Physicians who provide services at hospitals and facilities in the Mount Sinai Health System might not participate in the same health plans as those Mount Sinai hospitals and facilities (even if the physicians are employed or contracted by those hospitals or facilities).
Information regarding insurance participation and billing by this physician may be found on this page, and can also be obtained by contacting this provider directly. Because physicians insurance participation can change, the insurance information on this page may not always be up-to-date. Please contact this physician directly to obtain the most up-to-date insurance information.
Insurance and health plan networks that the various Mount Sinai Health System hospitals and facilities participate in can be found on the Mount Sinai Health System website.
Publications
Selected Publications
- An insider’s guide to understanding and obtaining an NIH K career development award. Don C. Rockey, Kyu Y. Rhee, Christopher S. Williams, Jatin M. Vyas, Charles W. Emala, Emily J. Gallagher. JCI insight
- Paving the physician-scientist career path: from grassroots gathering to national forum. Kyu Y. Rhee, Charles W. Emala, Emily Jane Gallagher, Don C. Rockey, Patrick J. Hu, Jatin M. Vyas, Daniel P. Cook, Tiffany C. Scharschmidt, Olujimi A. Ajijola, Christopher S. Williams. JCI insight
- Managing hyperglycemia and rash associated with alpelisib: expert consensus recommendations using the Delphi technique. Emily J. Gallagher, Heather Moore, Mario E. Lacouture, Susan F. Dent, Azeez Farooki, Marcus D. Goncalves, Claudine Isaacs, Abigail Johnston, Dejan Juric, Zoe Quandt, Laura Spring, Brian Berman, Melanie Decker, Gabriel N. Hortobagyi, Benjamin H. Kaffenberger, Bernice Y. Kwong, Timothy Pluard, Ruta Rao, Lee Schwartzberg, Michael S. Broder. npj Breast Cancer
Patient Experience Star Ratings and Comments
The Patient Experience Star Rating reflects our patients’ perception of how well their Mount Sinai provider communicated with them during an office visit. The Star Rating is based on patient responses to three questions on a patient experience survey, a standardized questionnaire sent to verified patients and distributed by a third party vendor, Press Ganey. Responses are measured on a scale of 1 to 5, with 5 being the best score.
Care Provider’s Explanation
Care Provider’s Concern
Likelihood to Recommend Care Provider
Industry Relationships
Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device, biotechnology companies, and other outside entities to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their outside financial relationships.
Below are financial relationships with industry reported by Dr. Gallagher during 2024 and/or 2025. Please note that this information may differ from information posted on corporate sites due to timing or classification differences.
Consulting or Other Professional Services Examples include, but are not limited to, committee participation, data safety monitoring board (DSMB) membership
- Reactive Biosciences
- Irish Clinical Academic Training (ICAT) Programme
- Novartis Pharmaceutical Corporation
- Flare Therapeutics
- German Federal Ministry of Education and Research
- Seagen
Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.
Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device, biotechnology companies, and other outside entities to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their outside financial relationships.
Below are financial relationships with industry reported by Dr. Gallagher during 2024 and/or 2025. Please note that this information may differ from information posted on corporate sites due to timing or classification differences.
Consulting or Other Professional Services Examples include, but are not limited to, committee participation, data safety monitoring board (DSMB) membership
- Reactive Biosciences
- Irish Clinical Academic Training (ICAT) Programme
- Novartis Pharmaceutical Corporation
- Flare Therapeutics
- German Federal Ministry of Education and Research
- Seagen
Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.